Ida Haisma, Director of the Leiden Bio Science Park Foundation, will step down at the end of 2023


Ida has shaped the further development of the Leiden Bio Science Park since 2019. Under her leadership, the Leiden Bio Science Park (LBSP) has been further transformed into an innovation district in the field of drug development and health in recent years. The LBSP is a vibrant and rapidly growing innovation ecosystem, currently consisting of more than 350 organizations with over 22,000 jobs and 21,000 students.

It is this foundation on which the Human Capital Agenda and the Multi-Year Vision and Ambition of the Leiden Bio Science Park were recently established, including an intended growth to 30,000 jobs and the further strengthening of our position at the absolute top of the international LSH campuses.

Building and creating an innovation district requires a long breath and is a very intensive process. The end of 2023 is therefore the right time for Ida to hand over the management and take a step towards a slightly different work-life balance.

The board is very grateful to Ida for her great contribution and will start the procedure for her succession in the coming weeks.


  • LUMC opens dedicated CAR-T department

    Leiden University Medical Center (LUMC) has opened a dedicated department for CAR-T cell therapy, bringing care, research and expertise in this rapidly developing field together in one place. The new department, officially opened on 24 September, marks another step in…

  • VarmX recognised with two prestigious industry award nominations

    Leiden-based biotech company VarmX has received two industry award nominations recognising its scientific approach and strategic partnership with CSL. VarmX has been shortlisted for the 2026 Prix Galien USA “Best Startup” Award, which recognises early-stage companies developing novel therapeutic approaches.…